id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-327463-uw3rhkf3	Xiao, Roy	Price Transparency for COVID-19 Testing Among Top US Hospitals	2020-09-18		.txt	text/plain	934	66	59	1 Under the CARES Act, private insurers are required to cover in vitro diagnostic testing for COVID-19 without patient cost sharing or other barriers during the public health emergency. To mitigate the risk of out-of-network billing for insurers that had not already negotiated rates, providers such as hospitals were required to publicly disclose the maximum "cash price" for tests online. We systematically reviewed the public websites of all hospitals in the 2019-2020 U.S. News and World Report "Best Regional Hospitals" list to determine whether the following information was available for in vitro COVID-19 tests: cash prices (yes/ no), hospital charges (yes/no), test type (molecular/serology/ unspecified; non-mutually exclusive). Among hospitals disclosing both cash prices and hospital charges, the median lowest bill balances for molecular (N = 27) and serology (N = 14) were $66.96 (IQR: $7.00-$120.00) and $6.00 (IQR: $6.00-$30.00), respectively.	./cache/cord-327463-uw3rhkf3.txt	./txt/cord-327463-uw3rhkf3.txt